We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00266383
First Posted: December 16, 2005
Last Update Posted: December 19, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Health Research Institutes, Taiwan
December 15, 2005
December 16, 2005
December 19, 2005
January 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00266383 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population
The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population
The human homologue of mice natural-resistance-associated macrophage protein 1 (Nramp 1) gene, NRAMP 1, has been reported to play a role in the susceptibility to tuberculosis in humans. The aboriginal population in Taiwan has a 5-fold higher prevalence of tuberculosis than the Han Chinese. Whether genetic factors such as NRAMP 1 polymorphisms play a role in the prevalence of tuberculosis in Taiwanese aboriginals should be clarified.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Tuberculosis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
250
December 2005
Not Provided

Inclusion Criteria:

  • The NRAMP 1 polymorphism of tuberculous patients in Taiwan.

Exclusion Criteria:

Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT00266383
DOH94-DC-1009
Not Provided
Not Provided
Not Provided
Not Provided
National Health Research Institutes, Taiwan
Not Provided
Principal Investigator: Ih-Jen Su, M.D., Ph.D. Division of Clinical Research, National Health Research Institutes
National Health Research Institutes, Taiwan
December 2005